Official UK procurement notice
Helix Biotech Biosimilar mRNA Vaccines
Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: UK
Awarded value£150,000published contract · exc. VAT
Awarded 10 Nov 2025no call for competition
Awarded to Helix Biotech Inc.2 awards
What is being bought
Published requirement descriptionVaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 4 Sept 2025, 13:53 BST
- Last source update
- 18 Dec 2025, 11:56 GMT
- Authority reference
C371747- FTS notice number
2025/S 000-084284- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-059422Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs). Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.
Review and risk notes
- Risks
A valid and current Cyber Essentials Certificate is required.
How it was run
Official notice- Submission deadline
- —
Timeline
19 Nov 2025 → 18 Dec 2025 · 2 dates- Standstill ends337 days ago19 Nov 2025, 23:59 GMT
- Notice published309 days ago18 Dec 2025, 11:56 GMT
Notice history
4 events · 3 releases on Find a Tender · since 4 Sept 2025- Transparency notice published4 Sept 2025, 13:53 BSTUK5
- Contract award notice published10 Nov 2025, 11:01 GMTUK6
- Contract signature expected24 Nov 2025, 23:59 GMTscheduled
- Contract details notice published18 Dec 2025, 11:56 GMTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 2
Awarded value £150,0001 contract exc. VAT · 1 repeated publication of the same award counted once
Contracts signed 1latest 17 Dec 2025
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Helix Biotech Inc.1 Dec 2025 – 30 Nov 2027 | £150,000same award published again · counted once | 10 Nov 2025standstill to 19 Nov 2025 | Standstill |
| Helix Biotech Inc. | £150,000 † | — | Awarded |
Contracts
Helix Biotech Biosimilar mRNA Vaccines · Helix Biotech Inc.
- Signed
- 17 Dec 2025
- Value
- £150,000
- Period
- 18 Dec 2025 – 17 Dec 2027
- Status
- active
1 agreed KPI: Certificate of Analysis
- Certificate of Analysis, Certificate of Analysis for each product produced
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Helix Biotech Inc.Awarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender